Welsh Executive annual general meeting focuses on pharmacy developments in Wales

Guest speakers Professor Akhtar (left) and Professor Dawson (right)
with Mair Davies |
The latest developments in pharmacy in Wales were highlighted during the annual general meeting of the Welsh Executive of the Royal Pharmaceutical Society held at Techniquest Science Discovery Centre, Cardiff Bay, on Wednesday 6 July.
Chairing the meeting, Mair Davies, chairman of the Welsh Executive for
2004–05, began by welcoming the Society’s devolution review.
She told the audience of 50 pharmacists from across Wales that the Welsh
Executive had participated fully in the review and it was now looking
forward to working towards the recommendations resulting from the reviw
group’s report which was published in January 2005. She urged every
member in Wales to engage with the process and to let their views be
known.
Mrs Davies went on to focus on the importance of collaboration with key
stakeholders to progress pharmacy issues as part of the wider health
agenda. In 2004 this had been achieved through the Quality Medicines
Management Conference held in November. Facilitated by the Welsh Executive
in partnership with the National Public Health Service and the South
East Wales Prescribing Advisory Group, the conference had brought together
key professionals in Wales with an interest in medicines management.
In addition, four regional workshops had been organised, with support
from the Welsh Assembly Government and the NPHS, to raise awareness of
the services that pharmacy has to offer in the substance misuse field.
Commenting on the work of the executive. Mrs Davies said: “The
success of the Welsh Executive depends upon our ability to represent
the profession effectively, the profession is you, the members, and communication
and collaboration is an essential cog in this wheel of success.”
Participants also heard presentations from Saghir Akhtar, director of
the Centre for Genome-based Therapeutics at Cardiff University, and Bill
Dawson, managing director of Bionet Ltd, about the impact of pharmacogenetics
on pharmacy.
The Welsh Executive’s annual review for 2004 was also launched
at the AGM. Copies have been distributed to all pharmacists in Wales
and further copies are available on the Welsh Executive’s website (see
also PDF 350K)
or by contacting Sarah Hickman (tel 029
2041 2800).
|